Crossref
1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif
Cancer Advances · 2022
DOI: 10.53388/2022522018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Advances, 2022. Verfasst von Davinder Kumar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kumar, D., Kumar, V., Kumar, H., Deep, A., & Kumar, R. (2022). 1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif. Cancer Advances. https://doi.org/10.53388/2022522018
Vancouver
Kumar D, Kumar V, Kumar H, Deep A, Kumar R. 1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif. Cancer Advances. 2022. doi:10.53388/2022522018
BibTeX
@article{Kumar2022,
author = {Kumar, Davinder and Kumar, Virender and Kumar, Harsh and Deep, Aakash and Kumar, Rakesh},
title = {1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif},
journal = {Cancer Advances},
year = {2022},
doi = {10.53388/2022522018}
}
EUVIMED